People in California suffer from various illnesses and injuries. There are also many doctors, hospitals and clinics who treat the people with these various illnesses and injuries. These medical professionals also have many different options to use for medications, medical equipment and medical services. There are also many different pharmaceutical companies who can make a lot of money when doctors choose to use their medications, medical equipment and services.
Since there are so many options, these pharmaceutical companies will look for any edge they can get, which includes giving doctors, hospitals and clinics kickbacks or bribes for choosing their company. This is illegal under federal law though and if people are caught doing it, they could be guilty of a felony. So, if it is happening these companies have big incentives to ensure that the authorities do not find out.
This means that if they are exposed by an employee, they may want to fire the employee who got them in trouble. This is also illegal though and the employee has protections from whistleblower retaliation. If an employer retaliates against an employee who exposes this illegal activity they may need to compensate the employee for doing this. This includes paying them back pay and potentially future pay as well as other damages depending on the circumstances. The employee could also be reinstated to their job as well.
Pharmaceutical companies and doctors, hospitals and clinics in California all can make a lot of money by providing medical services to those in need. They can make money legally and illegally by giving and taking kickbacks for using certain company’s products. If an employee for the pharmaceutical companies or the medical professionals expose this illegal activity, they should be able to do so without fearing that they will lose their job. If they do lose their job as a result, it is illegal and experienced attorneys may be able to help protect their rights.
Source: www.gpo.gov, “Title 42 § 1320a-7b. Criminal penalties for acts involving Federal health care programs” Oct. 11, 2017